Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alignment HealthcareALHC +0.41%81 3-Year EPS without NRI Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates ALHC with a GF Score™ of 81/100 and a GF Value™ of $20.68 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 17 Healthcare Plans companies, Alignment Healthcare ranks worse than 5882347.06% on this metric.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 7 years, the highest 3-Year average EPS without NRI Growth Rate of Alignment Healthcare was 16.80% per year. The lowest was -82.50% per year. And the median was -40.80% per year.
Alignment Healthcare (NAS:ALHC) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Alignment Healthcare 3-Year EPS without NRI Growth Rate Related Terms
ALHC vs PGNY, CLOV, PFHO: 3-Year EPS without NRI Growth Rate Comparison
For the Healthcare Plans subindustry, Alignment Healthcare's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alignment Healthcare 3-Year EPS without NRI Growth Rate vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Alignment Healthcare's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Alignment Healthcare's 3-Year EPS without NRI Growth Rate falls into.
Alignment Healthcare 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 0.00% mean?
Alignment Healthcare (ALHC) has a 3-Year EPS without NRI Growth Rate of 0.00% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Alignment Healthcare and its competitors. According to the industry distribution chart, Alignment Healthcare ranks #999999 out of 17 companies in the Healthcare Plans industry.
Is Alignment Healthcare's 3-Year EPS without NRI Growth Rate too high?
Alignment Healthcare's current 3-Year EPS without NRI Growth Rate is 0.00%. Based on the distribution chart, Alignment Healthcare ranks #999999 out of 17 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Alignment Healthcare has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alignment Healthcare's 3-Year EPS without NRI Growth Rate compare to PGNY and CLOV?
According to the Healthcare Plans industry distribution chart, Alignment Healthcare ranks #999999 out of 17 companies for 3-Year EPS without NRI Growth Rate. This places Alignment Healthcare in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 1.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Plans company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Plans companies is 1.40, based on 17 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Alignment Healthcare and its competitors. For the Healthcare Plans industry, the median 3-Year EPS without NRI Growth Rate is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alignment Healthcare's current 3-Year EPS without NRI Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alignment Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Alignment Healthcare (ALHC) is currently considered Significantly Undervalued. The stock's GF Value™ is $20.68, compared to a current price of $13.63 — trading 34.1% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 0.00%. Alignment Healthcare's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Alignment Healthcare (ALHC), the current 3-Year EPS without NRI Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alignment Healthcare (ALHC) Overvalued in 2026?
Based on GuruFocus' analysis, Alignment Healthcare stock appears to be undervalued.
The current stock price of $13.63 is trading 34.1% below its estimated GF Value™ of $20.68.
GuruFocus considers Alignment Healthcare to be Significantly Undervalued.
Key valuation signals for ALHC:
3-Year EPS without NRI Growth Rate: 0.00%
GF Value™: $20.68 vs. price of $13.63 (34.1% below fair value)
No single metric tells the full story. See the ALHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
81GF Score
Get the complete analysis for ALHC
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALHC has been successfully added to your 
